MADD anticorps (AA 1597-1647)
Aperçu rapide pour MADD anticorps (AA 1597-1647) (ABIN1978387)
Antigène
Voir toutes MADD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1597-1647
-
Specificité
- Region between residue 1597 and 1647 of human MAP kinase activating death domain using the numbering given in entry NP_003673.3 (GeneID 8567).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100 - 1:500)
Usage: Immunohistochemistry: Antigen retrieval is recommended. Antigen retrieval with citrate buffer will enhance staining. Likely to work with frozen sections. In some cases, the antibody may be diluted further than indicated. Human controls: Breast Carcinoma, Colon Carcinoma, Lung Adenocarcinoma, Ovarian Carcinoma, Prostate Carcinoma. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- MADD (MAP-Kinase Activating Death Domain (MADD))
-
Autre désignation
- DENN / MADD
-
Sujet
-
Name/Gene ID: MADD
Synonyms: MADD, DENN, IG20, KIAA0358, Rab3 GDP/GTP exchange factor, RAB3GEP -
ID gène
- 8567
-
Pathways
- Caspase Cascade in Apoptosis
Antigène
-